Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initially identified in Wuhan …

Coronavirus disease 2019 (COVID-19) has become a new public health crisis threatening
the world. Dysregulated immune responses are the most striking pathophysiological …

The key role of inflammation in COVID-19 induced many authors to study the cytokine storm,
whereas the role of other inflammatory mediators such as oxylipins is still poorly understood …

Specialized pro-resolving mediators (SPMs) derived from omega-3 fatty acids have
emerged as promising therapeutic agents for managing inflammatory diseases. This …

COVID-19 is characterised by a dysregulated immune response, that involves signalling
lipids acting as mediators of the inflammatory process along the innate and adaptive …

In response to different viral infections, including SARS-CoV-2 infection, pro-inflammatory,
anti-inflammatory cytokines, and bioactive lipids are released from infected and immune …

Coronavirus disease 2019 (COVID-19) has so far infected hundreds of million individuals,
with several million deaths worldwide. The lack of understanding of the disease …

Oxylipins are important signalling compounds that are significantly involved in the regulation
of the immune system and the resolution of inflammation. Lipid metabolism is strongly …

Anti‐inflammatory, specialized proresolving mediators such as resolvins, protectins,
maresins, and lipoxins derived from polyunsaturated acids may play a potential role in lung …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently regarded
as the twenty-first century's plague accounting for coronavirus disease 2019 (COVID-19) …